Abcam establishes direct service for ANZ

Monday, 18 August, 2014

Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors, which is expected to improve delivery times and better meet researchers’ needs.

“I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand,” said Abcam Commercial Director Philippe Cotrel.

Abcam’s in-house manufacturing facilities provide researchers with high-performance products such as primary and secondary antibodies, biochemicals, proteins, peptides, lysates and immunoassays. In addition, the company offers technical support and up-to-date datasheets.

“A direct service will enable us to develop closer relationships with our customers and ensure we are fully meeting their research needs,” said Cotrel.

Source

Related News

Virologist receives GSK Award for AI-based disease detection

Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his...

WA Govt creates Science and Technology Council

The council will offer independent advice on emerging opportunities and challenges, promoting...

Billion-dollar deal for UQ's molecular clamp vaccine tech

Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd